Education
About Us
Working with TipRanks
Follow Us
Acrux Limited (AU:ACR)
ASX:ACR
ACR Stock Chart & Stats
Day’s Range― - ―
52-Week RangeAU$0.02 - AU$0.08
Previous CloseN/A
Volume88.57K
Average Volume (3M)410.56K
Market Cap
$6.96M
Enterprise ValueAU$8.70M
Total Cash (Recent Filing)$3.33M
Total Debt (Recent Filing)$2.11M
Price to Earnings (P/E)―
Beta0.13
Next Earnings
Aug 22, 2025EPS EstimateN/A
Last Dividend Ex-Date
Aug 18, 2015Dividend YieldN/A
Share Statistics
EPS (TTM)-0.01
Shares Outstanding409,263,520
10 Day Avg. Volume434,488
30 Day Avg. Volume410,559
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap1.25
Enterprise Value/Revenue10.85
Enterprise Value/Gross Profit-4.79
Enterprise Value/Ebitda-0.97
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusModerate Sell
Number of Analyst Covering0
Acrux News
ACR FAQ
What was Acrux Limited’s price range in the past 12 months?
Acrux Limited lowest share price was AU$0.01 and its highest was AU$0.08 in the past 12 months.
What is Acrux Limited’s market cap?
Acrux Limited’s market cap is $6.96M.
When is Acrux Limited’s upcoming earnings report date?
Acrux Limited’s upcoming earnings report date is Aug 22, 2025 which is in 17 days.
How were Acrux Limited’s earnings last quarter?
Acrux Limited released its earnings results on Feb 25, 2025. The company reported -AU$0.011 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.011.
Is Acrux Limited overvalued?
According to Wall Street analysts Acrux Limited’s price is currently Overvalued.
Does Acrux Limited pay dividends?
Acrux Limited pays a Annually dividend of AU$0.06 which represents an annual dividend yield of N/A. See more information on Acrux Limited dividends here
What is Acrux Limited’s EPS estimate?
Acrux Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Acrux Limited have?
Acrux Limited has 409,263,520 shares outstanding.
What happened to Acrux Limited’s price movement after its last earnings report?
Acrux Limited reported an EPS of -AU$0.011 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -17.241%.
Which hedge fund is a major shareholder of Acrux Limited?
Currently, no hedge funds are holding shares in AU:ACR
Acrux Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Sell
Average Price Target:
― (―)
― (―)
Blogger Sentiment
Bullish
AU:ACR Sentiment 66%
Sector Average 71%
Sector Average 71%
News Sentiment
Neutral
Bullish news 59%
Bearish news 50%
Bearish news 50%
Technicals
SMA
―
20 days / 200 days
Momentum
-87.27%
12-Months-Change
Fundamentals
Return on Equity
-132.58%
Trailing 12-Months
Asset Growth
-41.17%
Trailing 12-Months
Company Description
Acrux Limited
Acrux Limited, together with its subsidiaries, develops and commercializes generic and topical pharmaceuticals in Australia, Europe, the United States, and internationally. The company offers testosterone solutions, such as oral tablets, buccal tablets, subcutaneous pellets, transdermal patches, injections, and topical gels for treatment of adult males who have low or no testosterone. It also provides estradiol sprays for women under the Evamist and Lenzetto brand names for the treatment of flushes associated with menopause. The company was incorporated in 1998 and is based in West Melbourne, Australia.
Technical Analysis
Living Cell Technologies Ltd.
―
Invex Therapeutics Ltd.
―
Chimeric Therapeutics Ltd.
―
Neuroscientific Biopharmaceuticals Ltd.
―
Memphasys Ltd
―
Ownership Overview
4.88% Insiders
―
Mutual Funds
― Other Institutional Investors
95.12% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---